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The objective of this thesis was to determine the prevalence and incidence of bovine viral 
diarrhoea (BVD) virus at cow and herd level, define risk factors for new infection and to 
quantify the impact at cow level of seroconversion during the seasonal breeding programme 
under the seasonal calving, pasture grazed systems in New Zealand. 
A questionnaire and bulk tank milk (BTM) BVD PCR and antibody ELISA test was 
completed for 402 New Zealand dairy herds, and repeated in the subsequent lactation. North 
Island herds had a high turnover rate with 67% of virus positive herds clearing infection each 
lactation and being replaced with newly infected herds, while the larger South Island herds 
rarely cleared infection naturally (14% per lactation) and maintained a higher prevalence 
(32% compared to 8.5% for North Island herds). Transmission pathways associated with bulk 
tank BVD status were purchasing cows, neighbour's stock, and stock movements off-farm. 
The other factors associated with bulk tank BVD status were herd size, herd BVD 
vaccination, and herd ownership structure.  
In 10 BTM PCR positive herds, all lactating cows (n=3,793) were tested for BVD antibody at 
the start of the seasonal breeding programme (planned start of mating; PSM), and again 125 
days later, to identify cows that seroconverted during the observation period. Improved cut-
off values were derived for the IDEXX milk antibody ELISA. There were few (3.8%) 
susceptible lactating cows at PSM in herds with a lactating persistently infected cow (PI), but 
most of these susceptible cows (82%) seroconverted. This required 4.6 contacts per PI each 
day. There were more susceptible (31%), and a smaller proportion of susceptible cows 
seroconverted (32%) in herds without a lactating PI. Seroconversion was associated with 
13% longer PSM to conception (3.2 days), 4% lower pregnancy rate, 6% lower conception to 
AI, and $11.97 (1.9 times) greater cost of clinical disease. The average cost per transient 
infection was $91.08.  
These results contributed to voluntary BVD control efforts in New Zealand and will be 
essential for developing a comprehensive cost-benefit model to estimate the average total cost 
of BVD, and assessing the benefit of various control strategies. 
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